If you haven`t bought the dip on ABBV: Then analyzing the options chain and the chart patterns of ABBV AbbVie prior to the earnings report this week, I would consider purchasing the 160usd strike price Calls with an expiration date of 2024-3-15, for a premium of approximately $7.55. If these options prove to be profitable prior to the earnings release, I would...
AbbVie (NYSE:ABBV) announced Thursday that it will acquire Immunogen (IMGN) and its flagship cancer therapy, Elahere, in a deal worth $31.26 per share. The transaction values ImmunoGen (NASDAQ:IMGN) at a total equity value of approximately $10.1 billion and is expected to close in the middle of 2024. Elahere is considered a "first-in-class antibody-drug...
ABBV is on a bearish 1D technical outlook (RSI = 39.987, MACD = -1.990, ADX = 42.078) but is quite possibly forming a short term bottom as the 1D RSI rebounded from an oversold level (under 30.00), while the MACD is close to forming a Bullish Cross. Every time those two conditions were fulfilled simultaneously inside the 1 year Channel Down, the price was a buy....
If you haven`t bought the dip on ABBV here: Then analyzing the options chain and the chart patterns of ABBV AbbVie prior to the earnings report this week, I would consider purchasing the 147usd strike price Calls with an expiration date of 2023-11-17, for a premium of approximately $3.30. If these options prove to be profitable prior to the earnings release, I...
Analyzing the options chain and the chart patterns of ABBV AbbVie prior to the earnings report this week, I would consider purchasing the 150usd strike price Calls with an expiration date of 2023-9-15, for a premium of approximately $2.46. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward to...
AbbVie Inc. (ABBV) is having the strongest 1D candle since October 13 2022, hitting the 1D MA200 (orange trend-line) for the first time in almost three months. The long-term pattern is a Channel Down and this one is the bullish leg to a new Lower High. The 1D RSI has breached into overbought (70.00>) territory so any pull-back is a buy, even on the current...
This idea is based on Wyckoff's method for determining price objectives using the Point & Figure count of distribution ranges. We can a distribution ranges following schematic 2 for Wyckoff's distribution. If we take count the ranges separately, this yields a potential reversal zone between 118.50 and 94.50 dollar per share. Personally I am intend to buy if...
Analyzing the options chain of ABBV AbbVie prior to the earnings report this week, I would consider purchasing the 175usd strike price Calls with an expiration date of 2024-1-19 for a premium of approximately $6.90. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. I am interested to hear your thoughts on...
ABBV has been in a down trend since the start of the year. With a break of the bear flag there is now only the long term trendline to save it.
AbbVie Inc. (ABBV) opened today much higher than the 1D MA200 (orange trend-line), which is a strong enough buy signal on its own. Coupled however with the fact that the rebound was achieved on the Higher Lows trend-line that started way back on the COVID (March 23 2020) market bottom, it makes it an even stronger one. In fact on a 2-3 month basis, this is the...
Hey traders, My weekly trade idea. The daily price is forming a textbook Cup&Handle formation. After the consolidation in the handle phase, the price is ready to go higher. The momentum will push the price and in my opinion, it is headed to test the all-time high in the 180$ area. The Relative Strength Index broke above its trend line and is moving upward to...
AbbVie has been in this uptrend for multiple years, lets ride. LONG
AbbVie - 30d expiry - We look to Sell a break of 132.58 (stop at 137.03) 133 continues to hold back the bears. 132.75 has been pivotal. Posted a Double Bottom formation. A break of the recent low at 132.74 should result in a further move lower. Our profit targets will be 121.01 and 117.01 Resistance: 154 / 157 / 160 Support: 147 / 142 / 137 Disclaimer –...
AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutics areas such as immunology, chronic kidney disease, hepatitis C, women's health, oncology, and neuroscience and also offers treatments for parkinson's, alzheimer's disease. I guess its stock can be down to $142 and below. My trade...
Betting on a further crash in AbbVie stock price. That huge candle preempts formal volatility switch. Fractally, hard to tell from this picture, possibly a start of a C in a WXY pattern. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with...
AbbVie Inc. Idea: Long Horizon: 1-2 months Target: $145 Entry range: $143-145 Stop order: $141 Technical analysis The share price has formed a short-term uptrend. If the local resistance level is broken through, there is a potential to move higher. Idea to increase the stock with the target of $145. Fundamental factor AbbVie is an American biopharmaceutical...
ABBV is one of Warren Buffet’s holding in BRK.B. It has been respecting the weekly wma50 for a long time while holding an uptrend. I think the sentiment has been too bearish & a shortterm rebound in the general market is due in the next few days. Not trading advice.3
NYSE:ABBV rsi in the oversold territory, which is starting to reverse to the bull side, flipped bullish on a micro timescale, falling wedge, breaking out to the upside, first target 140.75, then possible retest before 146.26. we've been in this long term downtrend channel since April 2022, I expect to break out of it, once we test 150.36 flip it as support then...